SynCore Biotechnology (4192) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 杏國

SynCore Biotechnology (4192) reported revenue of NT$2 million for Oct 2026, -0.3% year on year and -0.4% from the previous month. Revenue for Jan–Oct 2026 was NT$20.5 million (-5.7% year on year).

In Oct 2026, it ranked No. 143 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$1.7 million24/10Nov 2024 NT$1.9 millionDec 2024 NT$3.1 millionJan 2025 NT$1.8 millionFeb 2025 NT$1.4 million25/02Mar 2025 NT$2.2 millionApr 2025 NT$2.4 millionMay 2025 NT$3.4 millionJun 2025 NT$2.1 million25/06Jul 2025 NT$2.5 millionAug 2025 NT$2.1 millionSep 2025 NT$1.9 millionOct 2025 NT$2 million25/10Nov 2025 NT$2.7 millionDec 2025 NT$2.7 millionJan 2026 NT$2.1 millionFeb 2026 NT$1.9 million26/02Mar 2026 NT$2.1 millionApr 2026 NT$1.9 millionMay 2026 NT$2.7 millionJun 2026 NT$1.6 million26/06Jul 2026 NT$2.2 millionAug 2026 NT$1.8 millionSep 2026 NT$2 millionOct 2026 NT$2 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$2 million-0.3%-0.4%
Sep 2026NT$2 million+7.0%+9.4%
Aug 2026NT$1.8 million-12.0%-15.1%
Jul 2026NT$2.2 million-12.3%+33.6%
Jun 2026NT$1.6 million-22.5%-40.2%
May 2026NT$2.7 million-18.7%+41.7%
Apr 2026NT$1.9 million-18.6%-9.1%
Mar 2026NT$2.1 million-4.6%+13.8%
Feb 2026NT$1.9 million+33.9%-13.5%
Jan 2026NT$2.1 million+20.8%-19.7%
Dec 2025NT$2.7 million-12.3%+0.0%
Nov 2025NT$2.7 million+43.7%+32.5%
Oct 2025NT$2 million+20.7%+6.9%
Sep 2025NT$1.9 million+14.5%-10.0%
Aug 2025NT$2.1 million-22.3%-15.4%
Jul 2025NT$2.5 million+164.2%+18.0%
Jun 2025NT$2.1 million+10.3%-37.3%
May 2025NT$3.4 million+79.2%+41.9%
Apr 2025NT$2.4 million-28.6%+6.5%
Mar 2025NT$2.2 million+17.1%+59.8%
Feb 2025NT$1.4 million+59.0%-22.0%
Jan 2025NT$1.8 million+10.5%-41.7%
Dec 2024NT$3.1 million+43.2%+63.8%
Nov 2024NT$1.9 million-13.5%+11.2%
Oct 2024NT$1.7 million-11.7%+1.5%

Jan–Oct 2026 cumulative: NT$20.5 million (-5.7% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: SynCore Biotechnology vs PEC / SynCore Biotechnology vs Lotus Pharm / SynCore Biotechnology vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16